루이소체 치매의 진단과 치료
Diagnosis and Management of Dementia with Lewy Bodies
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Dementia with Lewy bodies (DLB) is considered the second most common cause of neurodegenerative dementia. It is charac- terized with clinical and pathological feature that distinguish it from Alzheimer’s disease (AD). These characteristics include fluc- tuating cognition, visual hallucination, and spontaneous feature of parkinsonism. DLB is commonly accompanied by neuropsy- chiatric symptoms and recent literature suggests that behavioral and psychological symptoms of dementia (BPDS) are frequently associated with DLB. So, psychiatrist caring for older adults may need a greater awareness of the clinical presentations of DLB in order to make a timely diagnosis. Also geriatric psychiatrist need to increase knowledge in order to raise awareness about the risks and benefits of medications in patients with DLB and to provide practical information and support for caregivers. This arti- cle reviews the clinical syndrome of DLB and its management.
Abstract
Dementia with Lewy bodies (DLB) is considered the second most common cause of neurodegenerative dementia. It is charac- terized with clinical and pathological feature that distinguish it from Alzheimer’s disease (AD). These characteristics include fluc- tuating cognition, visual hallucination, and spontaneous feature of parkinsonism. DLB is commonly accompanied by neuropsy- chiatric symptoms and recent literature suggests that behavioral and psychological symptoms of dementia (BPDS) are frequently associated with DLB. So, psychiatrist caring for older adults may need a greater awareness of the clinical presentations of DLB in order to make a timely diagnosis. Also geriatric psychiatrist need to increase knowledge in order to raise awareness about the risks and benefits of medications in patients with DLB and to provide practical information and support for caregivers. This arti- cle reviews the clinical syndrome of DLB and its management.
참고문헌 (62)
- McKeith I, "Dementia with Lewy bodies", Lancet Neurol, 3, pp.19~28 (2004)
- Holdorff B., "Friedrich Heinrich Lewy (1885-1950) and his work", J Hist Neurosci, 11, pp.19~28 (2002)
- Okazaki H, "Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion", J Neuropathol Exp Neurol, 20, pp.237~244 (1961)
- Kosaka K, "Presenile dementia with Alzheimer-, Pick- and Lewy-body changes", Acta Neuropathol, 36, pp.221~233 (1976)
- Kosaka K, "Lewy bodies in cerebral cortex, report of three cases", Acta Neuropathol, 42, pp.127~134 (1978)
- Kosaka K, "Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease", Clin Neuropathol, 3, pp.185~192 (1984)
- Lennox G, "Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry", J Neurol Neurosurg Psychiatry, 52, pp.1236~1247 (1989)
- Lennox G, "Diffuse Lewy body disease", Lancet, 1, pp.323~324 (1989)
- Byrne EJ, "Dementia and Parkinson’s disease associated with diffuse cortical Lewy bodies", Lancet, 1, pp.501~ (1987)
- Hansen L, "The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity", Neurology, 40, pp.1~8 (1990)
- Perry RH, "Senile dementia of Lewy body type and spectrum of Lewy body disease", Lancet, 1, pp.1088~ (1989)
- Gibb WR, "Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia)", Brain, 110(Pt 5), pp.1131~1153 (1987)
- McKeith IG, "Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop", Neurology, 47, pp.1113~1124 (1996)
- Zaccai J, "A systematic review of prevalence and incidence studies of dementia with Lewy bodies", Age Ageing, 34, pp.561~566 (2005)
- Galvin JE, "Lewy body dementia: the caregiver experience of clinical care", Parkinsonism Relat Disord, 16, pp.388~392 (2010)
- Galvin JE, "Lewy body dementia: caregiver burden and unmet needs", Alzheimer Dis Assoc Disord, 24, pp.177~181 (2010)
- McKeith IG, "Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium", Neurology, 65, pp.1863~1872 (2005)
- Whitworth HB, "A caregiver’s guide to Lewy body dementia", pp.37~40 (2011), Demoshealth
- Collerton D, "Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia", Dement Geriatr Cogn Disord, 16, pp.229~237 (2003)
- Galasko DR, "Continnum Lifelong Learning", Neurol Clin, 13, pp.69~86 (2007)
- Ferman TJ, "DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging", Neurology, 62, pp.181~187 (2004)
- Walker MP, "The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia", Br J Psychiatry, 177, pp.252~256 (2000)
- Mori T, "Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB", Neurology, 66, pp.935~937 (2006)
- Arnulf I, "Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis", Neurology, 55, pp.281~288 (2000)
- Boeve BF, "REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease", Neurology, 51, pp.363~370 (1998)
- Boeve BF, "REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies", J Geriatr Psychiatry Neurol, 17, pp.146~157 (2004)
- Duda JE, "Pathology and neurotransmitter abnormalities of dementia with Lewy bodies", Dement Geriatr Cogn Disord, 17(Suppl 1), pp.3~14 (2004)
- Borroni B, "Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment", Arch Gerontol Geriatr, 46, pp.101~106 (2008)
- Ricci M, "Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD)", Arch Gerontol Geriatr, 49, pp.e101~e104 (2009)
- Hansen LA, "Lewy body disease", Curr Opin Neurol Neurosurg, 5, pp.889~894 (1992)
- Burn DJ, "Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study", Mov Disord, 18, pp.884~889 (2003)
- Bradley BF, "Dementia with Lewy bodies", Neurlolgy, 10, pp.81~112 (2004)
- Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder", Neurology, 72, pp.1296~1300 (2009)
- Swanberg MM, "Benefit-risk considerations in the treatment of dementia with Lewy bodies", Drug Saf, 25, pp.511~523 (2002)
- McKeith I, "Neuroleptic sensitivity in patients with senile dementia of Lewy body type", BMJ, 305, pp.673~678 (1992)
- Aarsland D, "Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias", J Clin Psychiatry, 66, pp.633~637 (2005)
- McKeith IG, "Operational criteria for senile dementia of Lewy body type (SDLT)", Psychol Med, 22, pp.911~922 (1992)
- Imamura T, "Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer’s disease", Eur J Neurol, 7, pp.77~79 (2000)
- Orimo S, "Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease", Acta Neuropathol, 109, pp.583~588 (2005)
- Oka H, "Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease", Neurology, 69, pp.1460~1465 (2007)
- O’Brien JT, "Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia", Neurology, 56, pp.1386~1388 (2001)
- Hashimoto M, "Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study", Neurology, 51, pp.357~362 (1998)
- Barber R, "A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer’s disease: magnetic resonance imaging volumetric study", Dement Geriatr Cogn Disord, 12, pp.198~205 (2001)
- Cousins DA, "Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: an MRI study", Neurology, 61, pp.1191~1195 (2003)
- Walker Z, "Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand", J Neurol Neurosurg Psychiatry, 73, pp.134~140 (2002)
- Imamura T, "Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography", Dement Geriatr Cogn Disord, 12, pp.194~197 (2001)
- Lobotesis K, "Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD", Neurology, 56, pp.643~649 (2001)
- Donnemiller E, "Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease", Eur J Nucl Med, 24, pp.320~325 (1997)
- MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer’s-type and dementia with Lewy bodies, "J Neurol Neurosurg Psychiatry", 2001, 583~588
- Taki J, "Significance of 123IMIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease", Ann Nucl Med, 18, pp.453~461 (2004)
- Briel RC, "EEG findings in dementia with Lewy bodies and Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 66, pp.401~403 (1999)
- Graff-Radford J, "Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies", Brain, 135(Pt 8), pp.2470~2477 (2012)
- Omerovic M, "Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor", Nervenarzt, 78, pp.1052~1057 (2007)
- McKeith I, "Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study", Lancet, 356, pp.2031~2036 (2000)
- Emre M, "Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo- controlled trial", Lancet Neurol, 9, pp.969~977 (2010)
- Edwards K, "Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study", Dement Geriatr Cogn Disord, 23, pp.401~405 (2007)
- Mori E, "Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial", Ann Neurol, 72, pp.41~52 (2012)
- Molloy S, "The role of levodopa in the management of dementia with Lewy bodies", J Neurol Neurosurg Psychiatry, 76, pp.1200~1203 (2005)
- Bonelli SB, "L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia", Neurology, 63, pp.376~378 (2004)
- Lucetti C, "Levodopa response in dementia with lewy bodies: a 1-year followup study", Parkinsonism Relat Disord, 16, pp.522~526 (2010)
- Schenck CH, "Chronic behavioral disorders of human REM sleep: a new category of parasomnia", Sleep, 9, pp.293~308 (1986)
- Boeve BF, "Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients", Sleep Med, 4, pp.281~284 (2003)
